{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:14:31Z","timestamp":1790997271856,"version":"4.1.0"},"reference-count":118,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:00:00Z","timestamp":1625529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Cardiac fibrosis is the excess deposition of extracellular matrix (ECM), such as collagen. Myofibroblasts are major players in the production of collagen, and are differentiated primarily from resident fibroblasts. Collagen can compensate for the dead cells produced by injury. The appropriate production of collagen is beneficial for preserving the structural integrity of the heart, and protects the heart from cardiac rupture. However, excessive deposition of collagen causes cardiac dysfunction. Recent studies have demonstrated that myofibroblasts can change their phenotypes. In addition, myofibroblasts are found to have functions other than ECM production. Myofibroblasts have macrophage-like functions, in which they engulf dead cells and secrete anti-inflammatory cytokines. Research into fibroblasts has been delayed due to the lack of selective markers for the identification of fibroblasts. In recent years, it has become possible to genetically label fibroblasts and perform sequencing at single-cell levels. Based on new technologies, the origins of fibroblasts and myofibroblasts, time-dependent changes in fibroblast states after injury, and fibroblast heterogeneity have been demonstrated. In this paper, recent advances in fibroblast and myofibroblast research are reviewed.<\/jats:p>","DOI":"10.3390\/cells10071716","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T11:36:44Z","timestamp":1625571404000},"page":"1716","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":160,"title":["Cardiac Fibrosis and Fibroblasts"],"prefix":"10.3390","volume":"10","author":[{"given":"Hitoshi","family":"Kurose","sequence":"first","affiliation":[{"name":"Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMra1300575","article-title":"Fibrosis\u2014A Common Pathway to Organ Injury and Failure","volume":"372","author":"Rockey","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nrd.2016.89","article-title":"Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease","volume":"15","author":"Gourdie","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1007\/s12272-016-0809-6","article-title":"Myofibroblasts and inflammatory cells as players of cardiac fibrosis","volume":"39","author":"Kurose","year":"2016","journal-title":"Arch. Pharmacal Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.yjmcc.2013.10.006","article-title":"Dynamic cell-cell and cell-ECM interactions in the heart","volume":"70","author":"Howard","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00228448","article-title":"Collagen and the myocardium: Fibrillar structure, biosynthesis and degradation in relation to hypertro-phy and its regression","volume":"96","author":"Eghbali","year":"1990","journal-title":"Mol. Cell. Biochem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fcvm.2019.00020","article-title":"Angiogenic endothelial cell signaling in cardiac hypertrophy and heart failure","volume":"6","author":"Gogiraju","year":"2019","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.cell.2017.03.050","article-title":"Macrophages facilitate electrical conduction in the heart","volume":"169","author":"Hulsmans","year":"2017","journal-title":"Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.immuni.2013.11.019","article-title":"Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation","volume":"40","author":"Epelman","year":"2014","journal-title":"Immunity"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/01.CIR.98.7.699","article-title":"Resident Cardiac Mast Cells Degranulate and Release Preformed TNF-\u03b1, Initiating the Cytokine Cascade in Experimental Canine Myocardial Ischemia\/Reperfusion","volume":"98","author":"Frangogiannis","year":"1998","journal-title":"Circulation"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1097\/00004872-200310000-00022","article-title":"A role for cardiac mast cells in the pathogenesis of hypertensive heart disease","volume":"21","author":"Shiota","year":"2003","journal-title":"J. Hypertens."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/CIRCHEARTFAILURE.115.002225","article-title":"Left Ventricular T-Cell Recruitment Contributes to the Pathogenesis of Heart Failure","volume":"8","author":"Nevers","year":"2015","journal-title":"Circ. Hear. Fail."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"14680","DOI":"10.1038\/ncomms14680","article-title":"T cell costimulation blockade blunts pressure overload-induced heart failure","volume":"8","author":"Kallikourdis","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1161\/CIRCULATIONAHA.108.832782","article-title":"Regulatory T Cells Ameliorate Angiotensin II\u2013Induced Cardiac Damage","volume":"119","author":"Kvakan","year":"2009","journal-title":"Circulation"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00395-011-0232-6","article-title":"Regulatory T cells ameliorate cardiac remodeling after myocardial infarction","volume":"107","author":"Tang","year":"2012","journal-title":"Basic Res. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1161\/CIRCRESAHA.115.303895","article-title":"Foxp3 + CD4 + T Cells Improve Healing After Myocardial Infarction by Modulating Monocyte\/Macrophage Differentiation","volume":"115","author":"Weirather","year":"2014","journal-title":"Circ. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"H1233","DOI":"10.1152\/ajpheart.00328.2014","article-title":"Regulatory T cells are recruited in the infarcted mouse myocardium and may modulate fibroblast phenotype and function","volume":"307","author":"Saxena","year":"2014","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/CIRCRESAHA.115.307778","article-title":"Revisiting Cardiac Cellular Composition","volume":"118","author":"Pinto","year":"2016","journal-title":"Circ. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1161\/CIRCRESAHA.116.308139","article-title":"Recounting Cardiac Cellular Composition","volume":"118","author":"Zhou","year":"2016","journal-title":"Circ. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jbiomech.2009.09.020","article-title":"The myofibroblast: Paradigm for a mechanically active cell","volume":"43","author":"Hinz","year":"2010","journal-title":"J. Biomech."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.yjmcc.2017.11.012","article-title":"Resident fibroblast expansion during cardiac growth and remodeling","volume":"114","author":"Ivey","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s41592-018-0185-x","article-title":"Cellular barcoding: Lineage tracing, screening and beyond","volume":"15","author":"Kebschull","year":"2018","journal-title":"Nat. Methods"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.21037\/jtd.2017.03.122","article-title":"Cardiac fibroblasts: More than mechanical support","volume":"9","author":"Doppler","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"12260","DOI":"10.1038\/ncomms12260","article-title":"Genetic lineage tracing defines myofibroblast origin and function in the injured heart","volume":"7","author":"Kanisicak","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1172\/JCI74783","article-title":"Resident fibroblast line-ages mediate pressure overload-induced cardiac fibrosis","volume":"124","author":"Banerjee","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/CIRCRESAHA.115.303794","article-title":"Developmental Heterogeneity of Cardiac Fibroblasts Does Not Predict Pathological Proliferation and Activation","volume":"115","author":"Ali","year":"2014","journal-title":"Circ. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e140628","DOI":"10.1172\/jci.insight.140628","article-title":"Cardiac fibroblast proliferation rates and collagen expression ma-ture early and are unaltered with advancing age","volume":"17","author":"Wu","year":"2020","journal-title":"JCI insight"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1172\/JCI98215","article-title":"Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart","volume":"128","author":"Fu","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Yamada, S., and Nomura, S. (2020). Review of Single-Cell RNA Sequencing in the Heart. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218345"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1161\/CIRCULATIONAHA.119.043053","article-title":"Single-Cell Reconstruction of Progression Trajectory Reveals Intervention Principles in Pathological Cardiac Hypertrophy","volume":"141","author":"Ren","year":"2020","journal-title":"Circulation"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.celrep.2017.12.072","article-title":"Single-cell transcriptional pro-filing reveals cellular diversity and intercommunication in the mouse heart","volume":"22","author":"Skelly","year":"2018","journal-title":"Cell Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e43882","DOI":"10.7554\/eLife.43882","article-title":"Single-cell expression profiling reveals dynamic flux of cardiac stromal, vascular and immune cells in health and injury","volume":"8","author":"Farbehi","year":"2019","journal-title":"eLife"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1161\/CIRCULATIONAHA.119.045115","article-title":"High-Resolution Transcriptomic Profiling of the Heart During Chronic Stress Reveals Cellular Drivers of Cardiac Fibrosis and Hypertrophy","volume":"142","author":"McLellan","year":"2020","journal-title":"Circulation"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev-physiol-021119-034527","article-title":"Cardiac Fibroblast Diversity","volume":"82","author":"Tallquist","year":"2020","journal-title":"Annu. Rev. Physiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1016\/j.jacc.2019.10.036","article-title":"Transition of macrophages to fibroblast-like cells in healing myocardial infarction","volume":"74","author":"Haider","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_35","first-page":"585","article-title":"Mesenchymal-endothelial transition contributes to cardiac neovascularization","volume":"514","author":"Ubil","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1172\/JCI93868","article-title":"Preexisting endothelial cells mediate cardiac neovascularization after injury","volume":"127","author":"Xiuzhen","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1172\/JCI83822","article-title":"Cardiac myofibroblast engulfment of dead cells facilitates recovery after myocardial infarction","volume":"127","author":"Nakaya","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_38","first-page":"182","article-title":"Identification of a factor that links apoptotic cells to phagocytes","volume":"417","author":"Hanayama","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pharmthera.2018.01.001","article-title":"Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities","volume":"186","author":"Ong","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1161\/CIRCRESAHA.109.196287","article-title":"Heart-infiltrating prominin-1+\/CD133+ progenitor cells represent the cellular source of transforming growth factor beta-mediated cardiac fibrosis in experimental autoimmune myocarditis","volume":"105","author":"Kania","year":"2009","journal-title":"Circ. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fcvm.2020.00034","article-title":"Therapeutic Targets for the Treatment of Cardiac Fibrosis and Cancer: Focusing on TGF-\u03b2 Signaling","volume":"7","author":"Parichatikanond","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.yjmcc.2015.11.002","article-title":"Inflammatory and fibrotic responses of cardiac fibroblasts to myocardial damage associated molecular patterns (DAMPs)","volume":"94","author":"Turner","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","article-title":"The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis","volume":"119","author":"Prabhu","year":"2016","journal-title":"Circ. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"109816","DOI":"10.1016\/j.cellsig.2020.109816","article-title":"Neutrophil signaling during myocardial infarction wound repair","volume":"77","author":"Daseke","year":"2021","journal-title":"Cell. Signal."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/cvr\/cvv224","article-title":"BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia\u2013reperfusion injury","volume":"108","author":"Bovens","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"8749","DOI":"10.1096\/fj.202000041R","article-title":"Leukotriene B 4 receptor 1 exacerbates inflammation following myocardial infarction","volume":"34","author":"Horii","year":"2020","journal-title":"FASEB J."},{"key":"ref_47","first-page":"110","article-title":"IL-11 is a crucial determinant of cardiovascular fibrosis","volume":"552","author":"Viswanathan","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.yjmcc.2018.01.001","article-title":"Ablation of interleukin-17 alleviated cardiac interstitial fibrosis and improved cardiac function via inhibiting long non-coding RNA-AK081284 in diabetic mice","volume":"115","author":"Zhang","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCRESAHA.117.311071","article-title":"Resident and Monocyte-Derived Macrophages in Cardiovascular Disease","volume":"122","author":"Honold","year":"2018","journal-title":"Circ. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1096\/fj.12-214049","article-title":"Monocytes\/macrophages prevent healing defects and left ventricular thrombus formation after myocardial infarction","volume":"27","author":"Frantz","year":"2012","journal-title":"FASEB J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1172\/JCI94753","article-title":"Fibroblast-specific TGF-\u03b2-Smad2\/3 signaling underlies cardiac fibrosis","volume":"127","author":"Khalil","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/CIRCRESAHA.118.311403","article-title":"G-Protein\u2013Coupled Receptors in Heart Disease","volume":"123","author":"Wang","year":"2018","journal-title":"Circ. Res."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Zmajkovicova, K., Bauer, Y., Menyhart, K., Schnoebelen, M., Freti, D., Boucher, M., Renault, B., Studer, R., Birker-Robaczewska, M., and Klenk, A. (2020). GPCR-induced YAP activation sensitizes fibroblasts to profibrotic activity of TGF\u03b21. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0228195"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.pharmtox.010909.105753","article-title":"LPA Receptors: Subtypes and Biological Actions","volume":"50","author":"Choi","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrm2890","article-title":"Linking actin dynamics and gene transcription to drive cellular motile functions","volume":"11","author":"Olson","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1021\/acsptsci.8b00048","article-title":"Identification of Pirin as a Molecular Target of the CCG-1423\/CCG-203971 Series of Antifibrotic and Antimetastatic Compounds","volume":"2","author":"Lisabeth","year":"2019","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fphar.2019.00112","article-title":"G protein-coupled receptor kinase 2 (GRK2) as a potential therapeutic target in cardiovascular and metabolic diseases","volume":"10","author":"Murga","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/CIRCRESAHA.107.168336","article-title":"G Protein\u2013Coupled Receptor Kinase 2 Ablation in Cardiac Myocytes Before or After Myocardial Infarction Prevents Heart Failure","volume":"103","author":"Raake","year":"2008","journal-title":"Circ. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/CIRCRESAHA.116.309538","article-title":"Cardiac fibroblast GRK2 deletion enhances contractility and remodeling following ischemia\/reperfusion injury","volume":"119","author":"Woodall","year":"2016","journal-title":"Circ. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1038\/sj.emboj.7601417","article-title":"TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy","volume":"25","author":"Onohara","year":"2006","journal-title":"EMBO J."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.devcel.2012.08.017","article-title":"A TRPC6-dependent pathway for myofibroblast transdi ferentiation and wound healing in vivo","volume":"23","author":"Davis","year":"2012","journal-title":"Dev. Cell"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/CIRCULATIONAHA.116.026238","article-title":"Fibroblast-Specific Genetic Manipulation of p38 Mitogen-Activated Protein Kinase In Vivo Reveals Its Central Regulatory Role in Fibrosis","volume":"136","author":"Molkentin","year":"2017","journal-title":"Circulation"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41467-017-00840-w","article-title":"Loss of \u03b2-catenin in resident cardiac fibroblasts attenuates fibrosis induced by pressure over-load in mice","volume":"8","author":"Xiang","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.1038\/s41598-019-43430-0","article-title":"The Rho\/MRTF pathway inhibitor CCG-222740 reduces stellate cell activation and modulates immune cell populations in Kras G12D.; Pdx1-Cre (KC) mice","volume":"9","author":"Ana","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1161\/CIRCULATIONAHA.117.028752","article-title":"Fibroblast Primary Cilia Are Required for Cardiac Fibrosis","volume":"139","author":"Villalobos","year":"2019","journal-title":"Circulation"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e128722","DOI":"10.1172\/jci.insight.128722","article-title":"Cell-specific ablation of Hsp47 defines the collagen-producing cells in the injured heart","volume":"4","author":"Khalil","year":"2019","journal-title":"JCI Insight"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"109903","DOI":"10.1016\/j.cellsig.2020.109903","article-title":"RAS inhibition in resident fibroblast biology","volume":"80","author":"Garvin","year":"2021","journal-title":"Cell. Signal."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"H958","DOI":"10.1152\/ajpheart.00723.2018","article-title":"The renin-angiotensin system: Going beyond the classical paradigms","volume":"316","author":"Santos","year":"2019","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1089\/ars.2012.4550","article-title":"NADPH Oxidases in Heart Failure: Poachers or Gamekeepers?","volume":"18","author":"Zhang","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"101282","DOI":"10.1016\/j.redox.2019.101282","article-title":"Cysteine-based regulation of redox-sensitive Ras small GTPases","volume":"26","author":"Messina","year":"2019","journal-title":"Redox Biol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"8735","DOI":"10.1074\/jbc.R113.544635","article-title":"Role of metabolic H2O2 generation: Redox signaling and oxidative stress","volume":"289","author":"Sies","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.cardiores.2004.04.030","article-title":"TGF-\u03b21 and angiotensin networking in cardiac remodeling","volume":"63","author":"Rosenkranz","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Czepiel, M., Diviani, D., Ja\u017awa-Kusior, A., Tkacz, K., Rolski, F., Smolenski, R.T., Siedlar, M., Eriksson, U., Kania, G., and B\u0142yszczuk, P. (2021). Angiotensin II receptor 1 controls profibrotic Wnt\/\u03b2-catenin signalling in experimental autoimmune myocarditis. Cardiovasc. Res.","DOI":"10.1093\/cvr\/cvab039"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00395-018-0705-y","article-title":"The role of Wnt signaling in the healing myocardium: A focus on cell specificity","volume":"113","author":"Meyer","year":"2018","journal-title":"Basic Res. Cardiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41401-018-0060-4","article-title":"Wnt signaling pathways in myocardial infarction and the therapeutic effects of Wnt pathway inhibitors","volume":"40","author":"Fu","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Daskalopoulos, E., and Blankesteijn, W. (2021). Effect of Interventions in WNT Signaling on Healing of Cardiac Injury: A Systematic Review. Cells, 10.","DOI":"10.3390\/cells10020207"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCRESAHA.118.312589","article-title":"Topological Arrangement of Cardiac Fibroblasts Regulates Cellular Plasticity","volume":"123","author":"Yu","year":"2018","journal-title":"Circ. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.yjmcc.2015.11.025","article-title":"Mechanical control of cardiac myofibroblasts","volume":"93","author":"Shafieyan","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1161\/hy0202.102699","article-title":"Integrins Play a Critical Role in Mechanical Stress\u2013Induced p38 MAPK Activation","volume":"39","author":"Aikawa","year":"2002","journal-title":"Hypertension"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Herum, K.M., Lunde, I.G., McCulloch, A.D., and Christensen, G. (2017). The soft- and hard-heartedness of cardiac fibroblasts: Mecha-notransduction signaling pathways in fibrosis of the heart. J. Clin. Med., 6.","DOI":"10.3390\/jcm6050053"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1161\/CIRCRESAHA.116.303311","article-title":"The Hippo Pathway in Heart Development, Regeneration, and Diseases","volume":"116","author":"Zhou","year":"2015","journal-title":"Circ. Res."},{"key":"ref_82","first-page":"931","article-title":"Blockade of Fibroblast YAP Attenuates Cardiac Fibrosis and Dysfunction Through MRTF-A Inhibition","volume":"5","author":"Francisco","year":"2020","journal-title":"JACC: Basic Transl. Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"8345","DOI":"10.1002\/jcp.29678","article-title":"Matrix stiffness controls cardiac fibroblast activation through regulating YAP via AT 1 R","volume":"235","author":"Niu","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1074\/jbc.RA118.006123","article-title":"Yes-associated protein (YAP) mediates adaptive cardiac hypertrophy in response to pressure overload","volume":"294","author":"Byun","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"17693","DOI":"10.1074\/jbc.REV119.007963","article-title":"Control of cellular responses to mechanical cues through YAP\/TAZ regulation","volume":"294","author":"Dasgupta","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1101\/gad.329763.119","article-title":"Hippo pathway deletion in adult resting cardiac fibroblasts initiates a cell state transition with spontaneous and self-sustaining fibrosis","volume":"33","author":"Xiao","year":"2019","journal-title":"Genes Dev."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1021\/cb3003013","article-title":"Paroxetine Is a Direct Inhibitor of G Protein-Coupled Receptor Kinase 2 and Increases Myocardial Contractility","volume":"7","author":"Thal","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"277ra31","DOI":"10.1126\/scitranslmed.aaa0154","article-title":"Paroxetine-mediated GRK2 inhibition reverses cardiac dysfunction and remodeling after myocardial infarction","volume":"7","author":"Schumacher","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.bbagen.2013.09.017","article-title":"Aquaporin-facilitated transmembrane diffusion of hydrogen peroxide","volume":"1840","author":"Bienert","year":"2014","journal-title":"Biochim. Biophys. Acta (BBA)-Gen. Subj."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41569-019-0260-8","article-title":"NADPH oxidases and oxidase crosstalk in cardiovascular diseases: Novel therapeutic targets","volume":"17","author":"Zhang","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"eaay2176","DOI":"10.1126\/scitranslmed.aay2176","article-title":"Inhibition of aquaporin-1 prevents myocardial remodeling by blocking the transmembrane transport of hydrogen peroxide","volume":"12","author":"Montiel","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.trsl.2021.01.001","article-title":"Tyrosine kinases in the pathogenesis of tissue fibrosis in systemic sclerosis and potential therapeutic role of their inhibition","volume":"231","author":"Mendoza","year":"2021","journal-title":"Transl. Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s40119-020-00199-y","article-title":"Myocardial fibrosis in heart failure: Anti-fibrotic therapies and the role of cardi-ovascular magnetic resonance in drug trials","volume":"9","author":"Webber","year":"2020","journal-title":"Cardiol. Ther."},{"key":"ref_97","first-page":"430","article-title":"Targeting cardiac fibrosis with engineered T cells","volume":"573","author":"Aghajanian","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1161\/CIRCRESAHA.116.308643","article-title":"Targeted Ablation of Periostin-Expressing Activated Fibroblasts Prevents Adverse Cardiac Remodeling in Mice","volume":"118","author":"Kaur","year":"2016","journal-title":"Circ. Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.ymthe.2019.09.021","article-title":"CARdiac Immunotherapy: T Cells Engineered to Treat the Fibrotic Heart","volume":"27","author":"Vagnozzi","year":"2019","journal-title":"Mol. Ther."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"eaan5488","DOI":"10.1126\/scitranslmed.aan5488","article-title":"Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-\u03b2","volume":"10","author":"Lan","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jacc.2018.11.042","article-title":"Effects of Sacubitril\/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEF","volume":"73","author":"Zile","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jacc.2018.11.041","article-title":"Is Sacubitril\/Valsartan Antifibrotic?","volume":"73","author":"Zannad","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1161\/01.CIR.102.12.1388","article-title":"Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease","volume":"102","author":"Brilla","year":"2000","journal-title":"Circulation"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1161\/01.CIR.0000017264.66561.3D","article-title":"Losartan-Dependent Regression of Myocardial Fibrosis Is Associated With Reduction of Left Ventricular Chamber Stiffness in Hypertensive Patients","volume":"105","author":"Querejeta","year":"2002","journal-title":"Circulation"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1291\/hypres.28.787","article-title":"Impact of the angiotensin II receptor antagonist, losartan, on myocardial fibrosis in patients with end-stage renal disease: Assessment by ultrasonic integrated backscatter and biochemical markers","volume":"28","author":"Shibasaki","year":"2005","journal-title":"Hypertens. Res."},{"key":"ref_106","first-page":"480","article-title":"Effects of Losartan on Left Ventricular Hypertrophy and Fibrosis in Patients With Nonobstructive Hypertrophic Cardiomyopathy","volume":"1","author":"Shimada","year":"2013","journal-title":"JACC: Hear. Fail."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/FJC.0b013e3181d70690","article-title":"Candesartan Decreases Type III Procollagen-N-Peptide Levels and Inflammatory Marker Levels and Maintains Sinus Rhythm in Patients With Atrial Fibrillation","volume":"55","author":"Kawamura","year":"2010","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_108","first-page":"1239","article-title":"A Randomized Study of the Beneficial Effects of Aldosterone Antagonism on LV Function, Structure, and Fibrosis Markers in Metabolic Syndrome","volume":"4","author":"Kosmala","year":"2011","journal-title":"JACC: Cardiovasc. Imaging"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/heartjnl-2012-303329","article-title":"Fibrosis and cardiac function in obesity: A randomised controlled trial of aldosterone blockade","volume":"99","author":"Kosmala","year":"2013","journal-title":"Heart"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jacc.2009.08.021","article-title":"Natural history of markers of collagen turnover in patients with early diastolic dysfunction and impact of eplerenone","volume":"54","author":"Mak","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.cardfail.2011.04.007","article-title":"Results of the Randomized Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction Trial (RAAM-PEF)","volume":"17","author":"Deswal","year":"2011","journal-title":"J. Card. Fail."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.clinthera.2011.11.002","article-title":"Long-term statin therapy in patients with systolic heart failure and normal cholesterol: Effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide","volume":"34","author":"Abulhul","year":"2012","journal-title":"Clin. Ther."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.jacc.2003.12.052","article-title":"Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure","volume":"43","author":"Querejeta","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jacc.2007.04.080","article-title":"Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure","volume":"50","author":"Beaumont","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/HYPERTENSIONAHA.108.125278","article-title":"Impact of treatment on myocardial lysyl oxidase expression and collagen cross-linking in patients with heart failure","volume":"53","author":"Querejeta","year":"2009","journal-title":"Hypertension"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1161\/CIRCULATIONAHA.111.063412","article-title":"Chronic Inhibition of cGMP phosphodiesterase 5A improves diabetic cardiomyopathy: A randomized, controlled clinical trial using magnetic resonance imaging with myocardial tagging","volume":"125","author":"Giannetta","year":"2012","journal-title":"Circulation"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3389\/fphar.2017.00186","article-title":"A Clinical Perspective of Anti-Fibrotic Therapies for Cardiovascular Disease","volume":"8","author":"Fang","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jchf.2018.06.008","article-title":"Heart failure with preserved ejection fraction expert panel report: Current controversies and implications for clinical trials","volume":"6","author":"Parikh","year":"2018","journal-title":"JACC Heart Fail."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/7\/1716\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:26:52Z","timestamp":1760164012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/7\/1716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,6]]},"references-count":118,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["cells10071716"],"URL":"https:\/\/doi.org\/10.3390\/cells10071716","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints202105.0432.v1","asserted-by":"object"}]},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,6]]}}}